MAX
Company Analysis ProPhase Labs, Inc.
1. Summary
Advantages
- Price (0.16 $) is less than fair price (0.71 $)
- Current debt level 38.88% is below 100% and has decreased over 5 years from 46.82%.
Disadvantages
- Dividends (0%) are below the sector average (0.55%).
- The stock's return over the last year (-58.59%) is lower than the sector average (0.6%).
- The company's current efficiency (ROE=-188.11%) is lower than the sector average (ROE=102.4%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| ProPhase Labs, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -4.7% | -14.4% | -0.8% |
| 90 days | 33.3% | -9.5% | 0.2% |
| 1 year | -58.6% | 0.6% | 12.6% |
PRPH vs Sector: ProPhase Labs, Inc. has significantly underperformed the "Healthcare" sector by -59.19% over the past year.
PRPH vs Market: ProPhase Labs, Inc. has significantly underperformed the market by -71.22% over the past year.
Stable price: PRPH is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: PRPH with weekly volatility of -1.13% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (0.16 $) is lower than the fair price (0.71 $).
Price significantly below the fair price: The current price (0.16 $) is 343.8% lower than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (-0.12) is lower than that of the sector as a whole (29.98).
P/E vs Market: The company's P/E (-0.12) is higher than that of the market as a whole (-87.32).
5.3. P/BV
P/BV vs Sector: The company's P/BV (1.87) is lower than that of the sector as a whole (249.13).
P/BV vs Market: The company's P/BV (1.87) is lower than that of the market as a whole (82.22).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (2.03) is lower than that of the sector as a whole (127.74).
P/S vs Market: The company's P/S indicator (2.03) is lower than that of the market as a whole (115.2).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-1.16) is higher than that of the sector as a whole (-23.82).
EV/Ebitda vs Market: The company's EV/Ebitda (-1.16) is higher than that of the market as a whole (-82.75).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -189.41% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-189.41%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (172.16%).
6.4. ROE
ROE vs Sector: The company's ROE (-188.11%) is lower than that of the sector as a whole (102.4%).
ROE vs Market: The company's ROE (-188.11%) is lower than that of the market as a whole (-6.94%).
6.6. ROA
ROA vs Sector: The company's ROA (-68.8%) is lower than that of the sector as a whole (-1.94%).
ROA vs Market: The company's ROA (-68.8%) is lower than that of the market as a whole (37.49%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0.7%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.35%).
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.55%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.7.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (50.66%) are at a comfortable level.
Based on sources: porti.ru
